Co-authors

Researcher identifiers

Export Publications

Export the displayed publications:
Number of documents

10

Olivier Colliot - Research Director at CNRS - ARAMIS Lab (CNRS/INRIA/Inserm/UPMC)


Research Director at CNRS

 

Head of the ARAMIS Lab, a joint team between CNRSInriaInserm and University Pierre and Marie Curie at the Brain and Spine Institute (ICM), in co-direction with Didier Dormont.

 


"Harald Hampel"    Institut du Cerveau et de la Moëlle Epinière = Brain and Spine Institute   

Journal articles8 documents

  • Michel Thiebaut de Schotten, Hovagim Bakardjian, Habib Benali, Hugo Bertin, Joel Bonheur, et al.. Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, Elsevier, 2019, 15 (7), pp.940-950. ⟨10.1016/j.jalz.2019.03.006⟩. ⟨hal-02368904⟩
  • Enrica Cavedo, Michel J Grothe, Olivier Colliot, Simone Lista, Marie Chupin, et al.. Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease. Scientific Reports, Nature Publishing Group, 2017, 7 (1), pp.11706. ⟨10.1038/s41598-017-09780-3⟩. ⟨hal-01589622⟩
  • Thomas Jacquemont, Fabrizio de Vico Fallani, Anne Bertrand, Stéphane Epelbaum, Alexandre Routier, et al.. Amyloidosis and neurodegeneration result in distinct structural connectivity patterns in mild cognitive impairment. Neurobiology of Aging, Elsevier, 2017, ⟨10.1016/j.neurobiolaging.2017.03.023⟩. ⟨hal-01518785⟩
  • Stefan J Teipel, Enrica Cavedo, Michel J Grothe, Simone Lista, Samantha Galluzzi, et al.. Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's disease. Neuropharmacology, Elsevier, 2016, 108, pp.128-35. ⟨hal-01372417⟩
  • Enrica Cavedo, Bruno Dubois, Olivier Colliot, Simone Lista, Bernard Croisile, et al.. Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer’s Disease. Journal of Clinical Psychiatry, Physicians Postgraduate Press, 2016, ⟨10.4088/JCP.15m10413 ⟩. ⟨hal-01388951⟩
  • Bruno Dubois, Marie Chupin, Harald Hampel, Simone Lista, Enrica Cavedo, et al.. Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease. Alzheimer's and Dementia, Elsevier, 2015, 11 (9), pp.1041-1049. ⟨10.1016/j.jalz.2014.10.003⟩. ⟨hal-01249861⟩
  • Enrica Cavedo, Simone Lista, Zaven S Khachaturian, Paul S Aisen, Philippe Amouyel, et al.. The road ahead to cure Alzheimer’s disease: development of biological markers and neuroimaging methods for prevention trials across all stages and target populations. Journal of Prevention of Alzheimer’s Disease, 2014, 1 (3), pp.181-202. ⟨10.14283/jpad.2014.32⟩. ⟨hal-01098836⟩
  • Harald Hampel, Simone Lista, Stefan J Teipel, Francesco Garaci, Robert Nisticò, et al.. Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020. Biochemical Pharmacology, Elsevier, 2014, pp.426-49. ⟨hal-01098832⟩

Conference papers2 documents

  • Manon Ansart, Stéphane Epelbaum, Geoffroy Gagliardi, Olivier Colliot, Didier Dormont, et al.. Prediction of amyloidosis from neuropsychological and MRI data for cost effective inclusion of pre-symptomatic subjects in clinical trials. Multimodal Learning for Clinical Decision Support, Sep 2017, Quebec City, Canada. ⟨hal-01578422⟩
  • Anne Bertrand, Stephane Epelbaum, Marie-Odile Habert, Harald Hampel, Hovagim Bakardjian, et al.. The INSIGHT cohort: baseline analysis of structural MR imaging in asymptomatic subjects at risk for Alzheimer's disease. AAIC, Jul 2016, Toronto, Canada. ⟨10.1016/j.jalz.2016.06.612⟩. ⟨hal-01439571⟩